Design Therapeutics director resigns; Justin Gover appointed to board

Design Therapeutics, Inc.

Arsani William, M.D. resigned from board effective Sept 9, 2025, not due to any disagreement.
Board appointed Justin Gover as Class III director with term ending at 2027 annual meeting.
Gover also named chair of Compensation Committee.
Gover receives annual cash retainers of $40,000 for board service and $12,000 as committee chair.
Gover granted initial option for 30,000 shares vesting over 3 years and prorated grant of 15,833 shares vesting over 1 year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.